Faeth Therapeutics FTH
NASDAQ FTH
$20.57 -0.22 (-1.06%)
At close: Oct 21, 2026 · 4:00 PM EDT

Faeth Therapeutics (FTH) Liabilities and Shareholders Equity (2020 - 2026)

Updated

Faeth Therapeutics (FTH) recorded Liabilities and Shareholders Equity of $189.31 million in Q2 2026, up 495.6% from $31.78 million a year earlier but down 7.8% from the prior quarter.

Analysis

Faeth Therapeutics (FTH) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

At the end of FY2025, Faeth Therapeutics reported Liabilities and Shareholders Equity of $22.9 million, down 49.5% from FY2024.

  • Annual Liabilities and Shareholders Equity has declined for four straight years, though with a five-year compound annual growth rate of 1.3% (FY2020 to FY2025).
  • Across earlier years, Liabilities and Shareholders Equity came in at $45.36 million in FY2024 (-39.0%), $74.37 million in FY2023 (-37.2%), $118.38 million in FY2022 (-22.7%) and $153.23 million in FY2021 (+615.1%).
  • Quarterly Liabilities and Shareholders Equity has ranged from $22.9 million in Q4 2025 to $205.38 million in Q1 2026 over the past five years.
  • On a year-over-year basis, Liabilities and Shareholders Equity rose in two of the last eight quarters, with growth averaging 83.9%.
  • Peak year-over-year performance for Liabilities and Shareholders Equity in the last five years was growth of 615.1% in Q4 2021, against a decline of 49.5% in Q4 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $205.38 million (Q1 2026), $22.9 million (Q4 2025) and $27.59 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 142.28 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 201.06 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 135.12 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 129.80 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 115.83 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 95.64 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 49.36 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 201.13 Bn
10 Faeth Therapeutics 115.80 Mn -319.66 Mn - 189.31 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 189.31 Mn
Mar 31, 2026 205.38 Mn
Dec 31, 2025 22.90 Mn
Sep 30, 2025 27.59 Mn
Jun 30, 2025 31.78 Mn
Mar 31, 2025 38.27 Mn
Dec 31, 2024 45.36 Mn
Sep 30, 2024 53.25 Mn
Jun 30, 2024 59.80 Mn
Mar 31, 2024 66.70 Mn
Dec 31, 2023 74.37 Mn
Sep 30, 2023 81.66 Mn
Jun 30, 2023 89.58 Mn
Mar 31, 2023 107.93 Mn
Dec 31, 2022 118.38 Mn
Sep 30, 2022 128.80 Mn
Jun 30, 2022 138.04 Mn
Mar 31, 2022 150.04 Mn
Dec 31, 2021 153.23 Mn
Sep 30, 2021 161.25 Mn
API Access

Faeth Therapeutics Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=FTH&period=max&api_key=YOUR_API_KEY